Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Liver transplantation1521 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A48854 | 26585107 | Cesk Patol | [Recurrence of primary diseases after liver transplantation]. | 2015 | Details |
| A48862 | 26263921 | Clin Transplant | A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation. | 2015 | Details |
| A48884 | 25673576 | Br J Anaesth | Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. | 2015 | Details |
| A48885 | 25603848 | Korean J Gastroenterol | [Diagnostic and therapeutic strategies for severe alcoholic hepatitis]. | 2015 | Details |
| A48886 | 25557648 | Clin Transplant | Liver transplantation arrests and reverses muscle wasting. | 2015 | Details |
| A48887 | 25540733 | World J Transplant | Female gender in the setting of liver transplantation. | 2014 | Details |
| A48897 | 25263269 | Aliment Pharmacol Ther | Review article: the management of cirrhosis in women. | 2014 | Details |
| A48904 | 25040315 | Aliment Pharmacol Ther | The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US. | 2014 | Details |
| A48911 | 24796378 | Hepatol Res | Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. | 2014 | Details |
| A48915 | 24622872 | Z Gastroenterol | [Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases]. | 2014 | Details |
| A48925 | 24247485 | Nutr Diabetes | Very low calorie ketogenic weight reduction diet in patients with cirrhosis: a case series. | 2013 | Details |
| A48932 | 24090942 | Best Pract Res Clin Gastroenterol | Liver abnormalities and endocrine diseases. | 2013 | Details |
| A48941 | 23723127 | Catheter Cardiovasc Interv | Safety of transradial cardiac catheterization in patients with end-stage liver disease. | 2013 | Details |
| A48959 | 23180946 | World J Gastroenterol | Celiac disease markers in patients with liver diseases: a single center large scale screening study. | 2012 | Details |
| A48986 | 22271627 | Liver Transpl | Transient elastography identifies liver recipients with nonviral graft disease after transplantation: a guide for liver biopsy. | 2012 | Details |
| A48997 | 21999649 | Paediatr Drugs | Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases. | 2011 | Details |
| A49002 | 21734800 | World J Gastroenterol | Probiotics in hepatology. | 2011 | Details |
| A49007 | 21504529 | Transpl Infect Dis | Incidental hepatic schistosomiasis in a liver transplant recipient. | 2011 | Details |
| A49015 | 21281429 | Liver Int | Recurrence of non-viral liver disease after orthotopic liver transplantation. | 2011 | Details |
| A49065 | 19590654 | HPB (Oxford) | Simultaneous pancreatectomy and liver transplantation: a single-institution experience. | 2009 | Details |
| A49149 | 16215887 | Z Gastroenterol | Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH). | 2001 | Details |
| A49152 | 16185298 | Pathol Int | Post-liver transplantation de novo hepatitis with overlap features. | 2005 | Details |
| A49170 | 15629523 | J Hepatol | Recurrent non-alcoholic steatohepatitis in a living related liver transplant recipient. | 2005 | Details |
| A49192 | 14585066 | Expert Opin Drug Saf | Hepatotoxicity of thiazolidinediones. | 2003 | Details |
| A49213 | 35818022 | BMC Gastroenterol | Incidentalomas are associated with an increase in liver transplantation in patients with cirrhosis: a single-center retrospective study. | 2022 | Details |
| A49227 | 35814522 | J Clin Exp Hepatol | Overview of Complications in Cirrhosis. | 2022 | Details |
| A49231 | 35814515 | J Clin Exp Hepatol | Acute Graft Versus Host Disease Following Liver Transplantation: Case Report With Review of Current Literature. | 2022 | Details |
| A49232 | 35814511 | J Clin Exp Hepatol | Living Donor Liver Transplantation in a Cohort of Recipients With Left Ventricular Systolic Dysfunction. | 2022 | Details |
| A49235 | 35812989 | EClinicalMedicine | Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis. | 2022 | Details |
| A49314 | 35790893 | Biomol Ther (Seoul) | Polyploidization of Hepatocytes: Insights into the Pathogenesis of Liver Diseases. | 2022 | Details |
| A49338 | 35784533 | Front Endocrinol (Lausanne) | Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A49379 | 35769031 | Clin Transl Sci | The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease. | 2022 | Details |
| A49392 | 35765700 | Hepatol Commun | Growth hormone deficiency and NAFLD: An overlooked and underrecognized link. | 2022 | Details |
| A49432 | 35750138 | J Hepatol | Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. | 2022 | Details |
| A49433 | 35750137 | J Hepatol | Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. | 2022 | Details |
| A49483 | 35740254 | Biomedicines | Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49513 | 35729970 | Curr Treat Options Gastroenterol | Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement. | 2022 | Details |
| A49555 | 35715982 | Liver Transpl | Waitlist and Post-Transplantation Outcomes of Lean Individuals with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49570 | 35710086 | Ann Hepatol | African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population. | 2022 | Details |
| A49603 | 35693416 | Hepatobiliary Surg Nutr | Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient survival. | 2022 | Details |
| A49605 | 35693402 | Hepatobiliary Surg Nutr | Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience. | 2022 | Details |
| A49606 | 35693397 | Hepatobiliary Surg Nutr | Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients. | 2022 | Details |
| A49657 | 35677514 | J Clin Exp Hepatol | Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population. | 2021 | Details |
| A49659 | 35677507 | J Clin Exp Hepatol | Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India. | 2021 | Details |
| A49662 | 35677502 | J Clin Exp Hepatol | "Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India". | 2021 | Details |
| A49697 | 35666557 | JMIR Med Inform | Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores. | 2022 | Details |
| A49744 | 35651885 | Metabol Open | Effect of 8 Weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery. | 2022 | Details |
| A49773 | 35642526 | Expert Opin Emerg Drugs | Emerging drugs for the treatment of hepatocellular carcinoma. | 2022 | Details |
| A49815 | 35629086 | J Pers Med | Personalized Medicine for Liver Disease: From Molecular Mechanisms to Potential Targeted Therapies. | 2022 | Details |
| A49830 | 35625696 | Biomedicines | Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver. | 2022 | Details |
| A49855 | 35617968 | Semin Liver Dis | Non-alcoholic Fatty Liver Disease: Current Global Burden. | 2022 | Details |
| A49896 | 35605144 | Scand J Gastroenterol | Hepatocellular carcinoma in Stockholm, Sweden 2003-2018: a population-based cohort study. | 2022 | Details |
| A49905 | 35602098 | Oxid Med Cell Longev | A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. | 2022 | Details |
| A49910 | 35599922 | Ann Gastroenterol | Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis. | 2022 | Details |
| A49927 | 35592121 | Front Surg | Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction. | 2022 | Details |
| A49983 | 35572532 | Front Immunol | Reactive Oxygen Species Induce Fatty Liver and Ischemia-Reperfusion Injury by Promoting Inflammation and Cell Death. | 2022 | Details |
| A50013 | 35563534 | Int J Mol Sci | Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A50035 | 35553006 | Hepatol Int | Automated fibrosis phenotyping of liver tissue from non-tumor lesions of patients with and without hepatocellular carcinoma after liver transplantation for non-alcoholic fatty liver disease. | 2022 | Details |
| A50052 | 35545571 | Zhonghua Gan Zang Bing Za Zhi | [Nonalcoholic fatty liver disease and liver transplantation]. | 2022 | Details |
| A50085 | 35532955 | Metab Syndr Relat Disord | Nonalcoholic Fatty Liver Disease Patients Exhibit Reduced CD47 and Increased Sphingosine, Cholesterol, and Monocyte Chemoattractant Protein-1 Levels in the Erythrocyte Membranes. | 2022 | Details |
| A50109 | 35523460 | BMJ Open Gastroenterol | Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease. | 2022 | Details |
| A50169 | 35492028 | EMBO Rep | KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7. | 2022 | Details |
| A50205 | 35476028 | J Mol Med (Berl) | Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms. | 2022 | Details |
| A50226 | 35465068 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A50250 | 35456053 | Cells | Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids. | 2022 | Details |
| A50368 | 35414523 | J Clin Pathol | Paediatric non-alcoholic fatty liver disease: an approach to pathological evaluation. | 2022 | Details |
| A50472 | 35373876 | J Intern Med | Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study. | 2022 | Details |
| A50548 | 35345258 | Rev Cardiovasc Med | Cardiovascular events after liver transplantation: MACE hurts. | 2022 | Details |
| A50613 | 35325622 | Lancet Gastroenterol Hepatol | Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial. | 2022 | Details |
| A50664 | 35308580 | Curr Infect Dis Rep | Advances in Liver Transplantation for Persons with Human Immunodeficiency Infection. | 2022 | Details |
| A50701 | 35295066 | Saudi J Gastroenterol | Saudi association for the study of liver diseases and transplantation position statement on the hepatology workforce in Saudi Arabia. | 2022 | Details |
| A50913 | 33675319 | Transplantation | Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation. | 2022 | Details |
| A50942 | 35542850 | RSC Adv | Intrahepatic fatty acids composition as a biomarker of NAFLD progression from steatosis to NASH by using 1H-MRS. | 2019 | Details |
| A51017 | 25529627 | J Hepatol | Chronic kidney disease (CKD) and NAFLD: time for awareness and screening. | 2014 | Details |
| A51018 | 25529624 | J Hepatol | Reply to: "Chronic kidney disease (CKD) and NAFLD: time for awareness and screening". | 2014 | Details |
| A51083 | 12619426 | Acta Gastroenterol Belg | NASH/NAFLD management. | 2003 | Details |
| A51084 | 11584385 | Hepatology | NAFLD and NASH: important diseases before and after liver transplantation. | 2001 | Details |
| A51090 | 35803515 | Int J Surg | Clinical evidence of outcomes following liver transplantation in patients with nonalcoholic steatohepatitis: An updated meta-analysis and systematic review. | 2022 | Details |
| A51094 | 35783472 | Hepatol Forum | A single-center experience: Liver biopsy results during a year. | 2022 | Details |
| A51127 | 35611123 | Case Rep Gastroenterol | Acute Liver Injury and Acute Liver Failure following Bariatric Surgery. | 2022 | Details |
| A51304 | 35765128 | Transplantation | Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States. | 2022 | Details |
| A51332 | 35535116 | J Clin Exp Hepatol | An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. | 2021 | Details |
| A51361 | 35294954 | PLoS One | Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis. | 2022 | Details |
| A51373 | 33311893 | J Clin Exp Hepatol | Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes. | 2020 | Details |
| A51399 | 35814505 | J Clin Exp Hepatol | Surgical Risk Assessment in Patients with Chronic Liver Diseases. | 2022 | Details |
| A51401 | 35789987 | Pharmacoeconomics | The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review. | 2022 | Details |
| A51419 | 35676995 | Cureus | Pulmonary Hypertension as a Rare Complication After Orthotopic Liver Transplant in a Patient With Non-alcoholic Steatohepatitis (NASH) Cirrhosis Complicated by Hepatopulmonary Syndrome. | 2022 | Details |
| A51420 | 35665672 | Transplant Rev (Orlando) | A comprehensive review of coronary artery disease in patients with end-stage liver disease. | 2022 | Details |
| A51432 | 35445894 | Surg Case Rep | Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia. | 2022 | Details |
| A51435 | 35402726 | Clin Exp Hepatol | Impact of left ventricular diastolic dysfunction on liver transplantation outcomes based on the latest American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations. | 2021 | Details |
| A51439 | 35359027 | Am J Transplant | Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations. | 2022 | Details |
| A51442 | 35350934 | Prog Transplant | Life Expectancy after Liver Transplantation for NASH. | 2022 | Details |
| A51457 | 34693237 | JHEP Rep | Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287]. | 2021 | Details |
| A51465 | 33163949 | JHEP Rep | Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area. | 2020 | Details |
| A51511 | 35710982 | Nat Rev Gastroenterol Hepatol | Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. | 2022 | Details |
| A51567 | 35070003 | World J Hepatol | De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation. | 2021 | Details |
| A51616 | 35620719 | Front Med (Lausanne) | Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant. | 2022 | Details |
| A51629 | 35487614 | Clin Liver Dis | Chronic Kidney Disease After Liver Transplantation. | 2022 | Details |
| A51654 | 35224857 | Liver Transpl | Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation. | 2022 | Details |
| A51671 | 35068803 | J Clin Exp Hepatol | Versatility of Anabolic Androgenic Steroid-Induced Hepatotoxicity. | 2021 | Details |